A. Center Overview Project Abstract Diabetes mellitus is a significant health burden in the United States, affecting more than 20,000,000 people and costing more than $100 billion annually. The prevalence of Type 2 diabetes (T2DM) is growing rapidly; the CDC estimates that up to 1/3 of Americans will have diabetes by the year 2050. The burden of T2DM is particularly great among ethnic minority populations and those of lower socioeconomic status. The evidence base for the prevention and care of T2DM is one of the most well-established of any chronic illness: clinical trials have shown the efficacy of cardiometabolic therapies in preventing mortality and morbidity in diabetes, and programs such as the Diabetes Prevention Program (DPP) have demonstrated that diabetes can be prevented in high-risk patients. However, the overall quality of care for diabetes remains sub-optimal, significant disparities in diabetes care and prevention persist, and there are very few effective population- based efforts to systematically reduce prevent diabetes and reduce diabetes risk. Programs that can effectively translate high-quality, evidence-based diabetes prevention and treatment into widespread practice are desperately needed. In response to this need, diabetes researchers at the Kaiser Permanente Northern California Division of Research, HealthPartners Institute for Education and Research, Harvard Pilgrim Health Care Institute, and the University of California San Francisco (UCSF) created the Health Delivery Systems Center for Diabetes Translational Research (HDS-CDTR) in 2011 (P30 DK092924). This CDTR fosters and supports translational research in diabetes within health care delivery systems affiliated with the Health Care Systems Research Network (formerly known as the HMO Research Network) and with UCSF. The HDS- CDTR brings together a multi-disciplinary network of well-established investigators with a strong history of receiving federal and foundation funding in diabetes translational research. The HDS-CDTR is structured around three Translational Research Cores in the areas of health care disparities; diabetes and obesity prevention; and health information technology. HDS-CDTR investigators have strong relationships with delivery systems, ranging from large integrated delivery systems to networks of safety net providers that serve as key partners for translating effective interventions into real-world clinical settings. Our CDTR will continue to be a strong resource to under- resourced delivery systems across the U.S. through its Resource Core, which will continue and expand our support of these systems in their efforts to provide high quality diabetes prevention and care. In addition, the HDS-CDTR is expanding its mission to address disparities through the creation of a new Core for Underserved Populations that will develop a strong partnership with junior and senior Underrepresented Minority (URM) investigators at the Morehouse School of Medicine.
A. Center Overview Project Narrative The purpose of this renewal application is to continue and expand the work of the Health Delivery Systems Center for Diabetes Translational Research, a collaborative partnership between the Kaiser Permanente Northern California's Division of Research, HealthPartners Institute for Education and Research, Harvard Pilgrim Health Care Institute, and the University of California San Francisco. This Center leverages expertise in three Core Translational Research areas of diabetes prevention, health care disparities, and health IT to facilitate and disseminate high quality diabetes translational research across a range of delivery systems, including safety net and other under-resourced systems through its National Resource Core. The Center will also provide support to Underrepresented Minority Investigators in diabetes and diabetes prevention through its new collaboration with the Morehouse School of Medicine.
|Young, Deborah Rohm; Fischer, Heidi; Arterburn, David et al. (2018) Associations of overweight/obesity and socioeconomic status with hypertension prevalence across racial and ethnic groups. J Clin Hypertens (Greenwich) 20:532-540|
|Lu, Christine Y; Simon, Gregory; Soumerai, Stephen B et al. (2018) Counter-Point: Early Warning Systems Are Imperfect, but Essential. Med Care 56:382-383|
|Lu, Christine Y; Simon, Gregory; Soumerai, Stephen B (2018) Counter-Point: Staying Honest When Policy Changes Backfire. Med Care 56:384-390|
|Woo Baidal, Jennifer A; Elbel, Erin E; Lavine, Joel E et al. (2018) Associations of Early to Mid-Childhood Adiposity with Elevated Mid-Childhood Alanine Aminotransferase Levels in the Project Viva Cohort. J Pediatr 197:121-127.e1|
|Woo Baidal, Jennifer A; Cheng, Erika R; Rifas-Shiman, Sheryl L et al. (2018) Association of vitamin E intake at early childhood with alanine aminotransferase levels at mid-childhood. Hepatology 67:1339-1347|
|Cespedes Feliciano, Elizabeth M; Quante, Mirja; Rifas-Shiman, Sheryl L et al. (2018) Objective Sleep Characteristics and Cardiometabolic Health in Young Adolescents. Pediatrics 142:|
|Needham, Belinda L; Mukherjee, Bhramar; Bagchi, Pramita et al. (2018) Acculturation Strategies and Symptoms of Depression: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study. J Immigr Minor Health 20:792-798|
|Lacy, Mary E; Gilsanz, Paola; Karter, Andrew J et al. (2018) Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes. Diabetes Care 41:2339-2345|
|Mangurian, Christina; Modlin, Chelsea; Williams, Lindsey et al. (2018) A Doctor is in the House: Stakeholder Focus Groups About Expanded Scope of Practice of Community Psychiatrists. Community Ment Health J 54:507-513|
|Bradley, Marie C; Ferrara, Assiamira; Achacoso, Ninah et al. (2018) A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus. Cancer Epidemiol Biomarkers Prev 27:525-530|
Showing the most recent 10 out of 360 publications